This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Edwards Lifesciences Corp. advanced 3.1% to $81.39 on what proved to be an all-around poor trading session for the stock market, with the Dow Jones Industrial Average remaining mostly unchanged at 44,938.31 and the S&P 500 Index falling 0.2% to 6,395.78.
This was the stock's sixth consecutive day of gains.
Edwards Lifesciences Corp. closed 1.9% below its 52-week high of $83.00, which the company reached on July 25th.
The stock demonstrated a mixed performance when compared to some of its competitors, as Abbott Laboratories rose 0.9% to $132.44, Medtronic PLC rose 3.7% to $93.22, and Stryker Corp. rose 0.49% to $391.87.
Trading volume totaled 5.0 million, compared to the 50-day average of 4.2 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 20, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.